A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery

Clinical trial NCT04331080 · COMPLETED

Trial details

NCT number: NCT04331080
Sponsor: Xequel Bio, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Mammoplasty Scarring Scar Breast Reconstruction

Start date: 2020-07-01
Primary completion: 2022-05-26
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.